GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
The results add to evidence from animal studies and reports that people are finding the drugs helpful to manage cravings, not ...
New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.
Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...
MarketBeat on MSN5h
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsThe supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...
A Lilly USA LLC employee fired for allegedly misusing a corporate credit card failed to mount a viable claim that he was ...
PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...
Boris Becker's ex-wife Lilly looked on cloud nine as she touched down at Frankfurt Airport on Wednesday after winning the ...
Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...
Patients using Eli Lilly’s Mounjaro are being reminded that the KwikPen injection devices should be discarded after four doses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback